Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer
Min Zheng,1,* Shaoxing Li,1,* Jie Deng,1 Chaolin Huang,1 Hua Zhang2 1Department of Gynecology and Obstetrics, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, People’s Republic of China; 2Department of Rehabilitation Medicine, Clinical M...
Saved in:
Main Authors: | Zheng M, Li S, Deng J, Huang C, Zhang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/identification-and-clinical-validation-of-high-hsp60-expression-predic-peer-reviewed-fulltext-article-IJGM |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pre-treatment nutrition-related indicators and the prognosis of patients with newly diagnosed epithelial ovarian cancer: an ambispective cohort study
by: Shirui Wang, et al.
Published: (2025-01-01) -
Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy
by: Youzhao Ma, et al.
Published: (2024-12-01) -
A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis
by: Shiya Ji, et al.
Published: (2025-01-01) -
Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
by: Zhiyong Wan, et al.
Published: (2025-01-01) -
Predictive role of the prognostic nutritional index for long-term prognosis among patients undergoing pancreatoduodenectomy: a meta-analysis
by: Ying Liu, et al.
Published: (2025-01-01)